← Open Payments lookup

DIANA SMITH: Open Payments

NPI 1396121497 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$804 in 45 payments from 12 companies in 2025. Trend: 2023 $817 · 2024 $668 · 2025 $804

Food & beverage: $804
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$171
Novartis Pharmaceuticals Corporation6$153
Novo Nordisk Inc15$135
Takeda Pharmaceuticals U.S.A., Inc.4$118
Bayer Healthcare Pharmaceuticals Inc.3$65
PFIZER INC.2$43
GlaxoSmithKline, LLC.2$37
Hikma Pharmaceuticals USA1$23
SANOFI PASTEUR INC.1$17
Exact Sciences Corporation1$16

Products named: CUVITRU, Ozempic, Rhapsido, AIRSUPRA, Kerendia, Rybelsus, BREZTRI, FARXIGA.

Industry payments across AL — which companies pay providers there.